Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 40 citing articles:

Systemic Immune–Inflammation Index Predicts Prognosis of Cancer Immunotherapy: Systemic Review and Meta-Analysis
Bao‐Wen Tian, Yafei Yang, Chuncheng Yang, et al.
Immunotherapy (2022) Vol. 14, Iss. 18, pp. 1481-1496
Closed Access | Times Cited: 68
Evaluation of systemic immune-inflammation index for predicting late-onset fetal growth restriction
Fahri Burçin Fıratlıgil, Serap Topkara Sucu, Sitare Tuncdemir, et al.
Archives of Gynecology and Obstetrics (2024) Vol. 310, Iss. 1, pp. 433-439
Open Access | Times Cited: 12
Society for Immunotherapy of Cancer (SITC) consensus statement on essential biomarkers for immunotherapy clinical protocols
Tricia R. Cottrell, Michael T. Lotze, Alaa M. Ali, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 3, pp. e010928-e010928
Open Access | Times Cited: 1
Neutrophil in the Pancreatic Tumor Microenvironment
Lin Jin, Hong Sun Kim, Jiaqi Shi
Biomolecules (2021) Vol. 11, Iss. 8, pp. 1170-1170
Open Access | Times Cited: 45
The predictive value of inflammatory biomarkers for major pathological response in non-small cell lung cancer patients receiving neoadjuvant chemoimmunotherapy and its association with the immune-related tumor microenvironment: a multi-center study
Chongwu Li, Junqi Wu, Long Jiang, et al.
Cancer Immunology Immunotherapy (2022) Vol. 72, Iss. 3, pp. 783-794
Closed Access | Times Cited: 36
Prognostic value of systemic immune-inflammation index in patients with pancreatic cancer: a meta-analysis
Li Mao, Zhenlu Li, Zihe Wang, et al.
Clinical and Experimental Medicine (2022) Vol. 22, Iss. 4, pp. 637-646
Closed Access | Times Cited: 33
Focus on the Dynamics of Neutrophil-to-Lymphocyte Ratio in Cancer Patients Treated with Immune Checkpoint Inhibitors: A Meta-Analysis and Systematic Review
Yusheng Guo, Dongqiao Xiang, Jiayu Wan, et al.
Cancers (2022) Vol. 14, Iss. 21, pp. 5297-5297
Open Access | Times Cited: 33
Progresses in biomarkers for cancer immunotherapy
Xuwen Lin, Chenyu Zong, Zhihan Zhang, et al.
MedComm (2023) Vol. 4, Iss. 5
Open Access | Times Cited: 20
Survival and immunotoxicities in association with sex-specific body composition patterns of cancer patients undergoing immune-checkpoint inhibitor therapy – A systematic review and meta-analysis
Paul Trinkner, Sophie Günther, Ina Monsef, et al.
European Journal of Cancer (2023) Vol. 184, pp. 151-171
Closed Access | Times Cited: 19
Negative association of steroids with immunotherapy efficacy in a multi-tumor cohort: time and dose-dependent
Víctor Albarrán, Patrícia Guerrero, Coral García de Quevedo, et al.
Cancer Immunology Immunotherapy (2024) Vol. 73, Iss. 10
Open Access | Times Cited: 7
Tumour‐associated neutrophils: Potential therapeutic targets in pancreatic cancer immunotherapy
Qihang Wu, Han Mao, Zhengting Jiang, et al.
Immunology (2024) Vol. 172, Iss. 3, pp. 343-361
Closed Access | Times Cited: 6
Prognostic and clinicopathological significance of systemic immune-inflammation index in pancreatic cancer: a meta-analysis of 2,365 patients
Yifang Shui, Mengquan Li, Jing Su, et al.
Aging (2021) Vol. 13, Iss. 16, pp. 20585-20597
Open Access | Times Cited: 41
Prognostic and clinicopathological significance of Systemic Immune-Inflammation Index in cancer patients receiving immune checkpoint inhibitors: a meta-analysis
Yan Wang, Qunqin Ni
Annals of Medicine (2023) Vol. 55, Iss. 1, pp. 808-819
Open Access | Times Cited: 14
Predictive value of immunotherapy-induced inflammation indexes: dynamic changes in patients with nasopharyngeal carcinoma receiving immune checkpoint inhibitors
Jia‐Xin Cao, Qun Chen, Xue Bai, et al.
Annals of Medicine (2023) Vol. 55, Iss. 2
Open Access | Times Cited: 14
Cancer Immunotherapy with Immune Checkpoint Inhibitors-Biomarkers of Response and Toxicity; Current Limitations and Future Promise
Brian Bird, Kenneth Nally, Karine Ronan, et al.
Diagnostics (2022) Vol. 12, Iss. 1, pp. 124-124
Open Access | Times Cited: 22
Biomarkers for Outcome in Metastatic Melanoma in First Line Treatment with Immune Checkpoint Inhibitors
Tanja Mesti, Cvetka Grašič Kuhar, Janja Ocvirk
Biomedicines (2023) Vol. 11, Iss. 3, pp. 749-749
Open Access | Times Cited: 13
Updates on Titanium Dioxide

IntechOpen eBooks (2023)
Open Access | Times Cited: 13
Associations between Nutritional and Immune Status and Clinicopathologic Factors in Patients with Pancreatic Cancer: A Comprehensive Analysis
Beata Jabłońska, Krzysztof Pawlicki, Sławomir Mrowiec
Cancers (2021) Vol. 13, Iss. 20, pp. 5041-5041
Open Access | Times Cited: 26
TiSe2-mediated sonodynamic and checkpoint blockade combined immunotherapy in hypoxic pancreatic cancer
Libin Chen, Xue Wang, Jing Cao, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 19
Association of inflammatory markers with survival in patients with advanced gastric cancer treated with immune checkpoint inhibitors combined with chemotherapy as first line treatment
Mingyu Wan, Yongfeng Ding, Chenyu Mao, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 17
Evaluation of the Relationship Between Systemic Immune-Inflammatory Index and Morning Blood Pressure Surge in Newly Diagnosed Essential Hypertension Patients
Muhammet Salih Ateş, Fikret Keleş
Ahi Evran Medical Journal (2025) Vol. 9, Iss. 1, pp. 24-29
Open Access
The Predictive Value of Systemic Immune-Inflammation Index on Bladder Recurrence on Upper Tract Urothelial Carcinoma Outcomes after Radical Nephroureterectomy
Tsu‐Ming Chien, Ching‐Chia Li, Yen-Man Lu, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 22, pp. 5273-5273
Open Access | Times Cited: 21
Neutrophils in pancreatic cancer: Potential therapeutic targets
Wenkai Jiang, Xin Li, Caifei Xiang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 14
Complete Blood Count-Derived Inflammatory Markers Changes in Dogs with Chronic Inflammatory Enteropathy Treated with Adipose-Derived Mesenchymal Stem Cells
José Ignacio Cristóbal, Francisco Javier Duque, Jesús M. Usón‐Casaús, et al.
Animals (2022) Vol. 12, Iss. 20, pp. 2798-2798
Open Access | Times Cited: 13
Predictive value of early dynamic changes of NLR and PLR for the efficacy of immune checkpoint inhibitor in head and neck squamous cell carcinoma
Dong Hyun Kim, Seo Yoon Jang, Bhumsuk Keam
Oral Surgery Oral Medicine Oral Pathology and Oral Radiology (2024) Vol. 138, Iss. 6, pp. 763-771
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top